Table 2 Characteristics of bilateral adrenal tumors larger than 50 mm
From: Clinical analysis of adrenal lesions larger than 5 cm in diameter (an analysis of 251 cases)
Diagnosis | Number n = 32 | Age (years) (mean ± SD) | Male/female | diameter (cm) (mean ± SD) | |
|---|---|---|---|---|---|
R | L | ||||
Benign adenoma | 5 (15.63%) | 64.80 ± 9.24 | 5/0 | 2.64 ± 2.04 | 5.72 ± 2.96 |
Cortical carcinoma | 5 (15.63%) | 52.40 ± 12.18 | 3/2 | 8.95 ± 3.12 | 5.49 ± 4.51 |
Myelolipoma | 2 (6.25%) | 53.50 ± 6.50 | 1/1 | 7.85 ± 0.55 | 1.40 ± 0.60 |
Lymphoma | 2 (6.25%) | 74 ± 1 | 0/2 | 4.02 ± 1.49 | 6.93 ± 0.53 |
Gangliocytoma | 1 (3.13%) | 54 | 1/0 | 7.50 | 4.00 |
Pheochromocytoma | 1 (3.13%) | 66 | 0/1 | 6.50 | 0.60 |
Metastatic carcinoma | (50.00%) | ||||
Lung cancer | 8 (25.00%) | 62.63 ± 9.14 | 6/2 | 4.85 ± 3.68 | 4.02 ± 1.94 |
Kidney cancer | 2 (6.25%) | 61.50 ± 1.50 | 2/0 | 4.90 ± 0.70 | 5.15 ± 3.35 |
Intestinal malignancy | 2 (6.25%) | 64.50 ± 0.50 | 2/0 | 2.25 ± 0.75 | 6.83 ± 0.17 |
Prostate cancer | 1 (3.13%) | 80 | 1/0 | 1.80 | 6.05 |
Urothelial carcinoma | 1 (3.13%) | 84 | 1/0 | 10.73 | 4.00 |
Liver cancer | 1 (3.13%) | 63 | 1/0 | 5.53 | 5.00 |
Melanoma | 1 (3.13%) | 45 | 1/0 | 1.95 | 15.16 |